TABLE 1

Radiation Absorbed Doses per Unit Administered Activity from Intravenous Administration of 111In-Ibritumomab Tiuxetan

Target organmGy/MBq
Adrenals0.202 ± 0.041
Brain0.082 ± 0.020
Breasts0.080 ± 0.016
Gallbladder wall0.229 ± 0.059
Lower large intestine0.130 ± 0.027
Small intestine0.145 ± 0.027
Stomach wall0.139 ± 0.028
Upper large intestine wall0.147 ± 0.027
Heart wall0.195 ± 0.048
Kidneys0.315 ± 0.071
Liver0.467 ± 0.202
Lungs0.152 ± 0.036
Muscle0.103 ± 0.021
Ovaries0.138 ± 0.028
Pancreas0.199 ± 0.041
Red marrow0.272 ± 0.065
Osteogenic cells*0.312 ± 0.050
Skin0.065 ± 0.015
Spleen0.464 ± 0.193
Testes0.175 ± 0.076
Thymus0.114 ± 0.024
Thyroid0.098 ± 0.024
Urinary bladder wall0.113 ± 0.028
Uterus0.132 ± 0.029
Total body0.124 ± 0.022
  • * Bone surfaces.

  • Data are mean ± SD. Three significant figures do not imply precision of 1 in 1,000.